title: Low doses of low molecular weight heparin in vivo do not inhibit delayed-type hypersensitivity.
authors.forename: C O
authors.initials: CO
authors.lastname: Zachariae
authors.forename: C G
authors.initials: CG
authors.lastname: Larsen
authors.forename: P D
authors.initials: PD
authors.lastname: Thomsen
authors.forename: J
authors.initials: J
authors.lastname: Nowak
authors.forename: R
authors.initials: R
authors.lastname: Zachariae
authors.forename: T
authors.initials: T
authors.lastname: Menné
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D001707:Biopsy, Needle; D004195:Disease Models, Animal; D004305:Dose-Response Relationship, Drug; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000473:pathology / Q000517:prevention & control*; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D011817:Rabbits; D051381:Rats; D012016:Reference Values; D012867:Skin / Q000187:drug effects / Q000473:pathology*; D013045:Species Specificity; D014374:Tuberculin Test
chemical_list: D006495:Heparin, Low-Molecular-Weight